Occudo Quantitative Strategies’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-26,310
Closed -$4.66M 1026
2022
Q3
$4.66M Buy
+26,310
New +$5.2M 0.36% 42
2022
Q2
Sell
-18,145
Closed -$4.32M 1166
2022
Q1
$4.32M Buy
18,145
+14,613
+414% +$3.43M 0.36% 40
2021
Q4
$807K Sell
3,532
-19,281
-85% -$4.24M 0.07% 440
2021
Q3
$4.41M Buy
22,813
+17,199
+306% +$3.48M 0.53% 9
2021
Q2
$1.19M Buy
+5,614
New +$1.19M 0.18% 170
2021
Q1
Sell
-1,572
Closed -$286K 780
2020
Q4
$286K Buy
+1,572
New +$267K 0.09% 424

Other funds holding CME

Occudo Quantitative Strategies's CME Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of CME Group (CME) in Q4 2022, closing a stake of 26,310 shares — an estimated $4.66M sold.

Occudo Quantitative Strategies first reported a position in CME in Q4 2020 and held it in 6 quarters. The position peaked at $4.66M in Q3 2022. 1,149 funds tracked by Wall St. Rank hold CME as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining CME Group position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 26,310 CME Group shares in Q4 2022, an estimated $4.66M.
  • Occudo Quantitative Strategies first reported a position in CME Group in Q4 2020 and held it in 6 quarters.
  • Occudo Quantitative Strategies's CME Group position peaked at $4.66M in Q3 2022.
  • 1,149 funds tracked by Wall St. Rank held CME Group as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.